Any positives?, page-8

The positive is is that none of the products have failed - the main issue is more about delays... delays in seeing revenue.

Yes its disappointing, .....
... but the products, aside from some manufacturing issues around the covid test (which they have fixed or are in the process of fixing ) work - its just going to take abit longer to see actual revenues.

There's only 4 months left of this financial year, but its very likely we will see revenues from the covid test later this calendar year; so this coming financial year 22/23 we should see revenues in 1H and potentially some revenues from a multiplex flu/covid test in the half half of the financial year.
Once we enter the market we will be one of the best tests on the market with a full set of test data backing us up - we only need to sell 20m tests to be making good money and while global demand may wax and wane for tests, there will always be a need for an accurate test, whether its in hospitals, nursing homes, doctors, cruise ships - which is the areas we were always looking at. And I see a new variant is about to hit with cases numbers in NSW expected to double

We also have potential to begin earning from the battery space around AnteoX and/or sign agreements with a potential upfront payment or milestone payments, which could occur anytime in 22/23, but an initial agreement could still occur this financial year.

Sepsis revenues should begin to occur 1H 22/23

We have 16m in cash this will last until 2024 I reckon.

So no its not total doom